This was similar to previous reports, which demonstrated that liver markers, e.g., ALT, AST, and gamma-glutamyl transferase (GGT), were biomarkers for chronic diseases, e.g., NAFLD, T2D, and MS (9, 17–19, 36–39). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.